Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5935/0004-2749.20200067 http://scihub22266oqcxt.onion/10.5935/0004-2749.20200067 32490972!11826647!32490972     free     free     free Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32490972.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Arq+Bras+Oftalmol 2020 ; 83 (3): 250-261 Nephropedia Template TP {{tp|p=32490972|t=2020. COVID-19 and the eye: how much do we really know? A best evidence review |pdf=|usr=}}{{32490972}} gab.com Text COVID-19 and the eye: how much do we really know A best evidence review JO: Arq Bras Oftalmol http://www.kidney.de/pget.php?&tw=1&pmid=32490972 #FOAvip To identify and classify available information regarding COVID-19 and eye care according to the level of evidence, within four main topics of interest: evidence of the virus in tears and the ocular surface, infection via the conjunctival route, ocular manifestations, and best practice recommendations. A structured review was conducted in PubMed, ScienceDirect, LILACS, SciELO, the Cochrane Library and Google Scholar on COVID-19 and ophthalmology. The Oxford Centre for Evidence Based Medicine 2011 Levels of Evidence worksheet was used for quality assessments. 1018 items were identified in the search; 26 records were included in the qualitative synthesis, which encompassed 6 literature reviews, 10 case series or cross-sectional studies, 4 case reports, and 6 intervention descriptions. Seventeen out of 26 records (65%) were categorized as level 5 within the Oxford CBME methodology grading system, the rest were level 4. The evidence generated on COVID-19 and ophthalmology to date is limited, although this is understandable given the circumstances. Both the possible presence of viral particles in tears and conjunctiva, and the potential for conjunctival transmission remain controversial. Ocular manifestations are not frequent and could resemble viral infection of the ocular surface. Most recommendations are based on the strategies implemented by Asian countries during previous coronavirus outbreaks. There is a need for substantive studies evaluating these strategies in the setting of SARS-CoV-2. In the meantime, plans for applying these measures must be implemented with caution, taking into account the context of each individual country, and undergo regular evaluation. Twit Text FOAVip COVID-19 and the eye: how much do we really know A best evidence review ????Arq Bras Oftalmol http://www.kidney.de/pget.php?&tw=1&pmid=32490972 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32490972 #FOAvip English Wikipedia <ref>{{Cite pmid|32490972}}</ref> COVID-19 and the eye: how much do we really know? A best evidence review #MMPMID32490972 Emparan JPO; Sardi-Correa C; Lopez-Ulloa JA; Viteri-Soria J; Penniecook JA; Jimenez-Roman J; Lansingh VC Arq Bras Oftalmol 2020[Jun]; 83 (3): 250-261 PMID32490972show ga To identify and classify available information regarding COVID-19 and eye care according to the level of evidence, within four main topics of interest: evidence of the virus in tears and the ocular surface, infection via the conjunctival route, ocular manifestations, and best practice recommendations. A structured review was conducted in PubMed, ScienceDirect, LILACS, SciELO, the Cochrane Library and Google Scholar on COVID-19 and ophthalmology. The Oxford Centre for Evidence Based Medicine 2011 Levels of Evidence worksheet was used for quality assessments. 1018 items were identified in the search; 26 records were included in the qualitative synthesis, which encompassed 6 literature reviews, 10 case series or cross-sectional studies, 4 case reports, and 6 intervention descriptions. Seventeen out of 26 records (65%) were categorized as level 5 within the Oxford CBME methodology grading system, the rest were level 4. The evidence generated on COVID-19 and ophthalmology to date is limited, although this is understandable given the circumstances. Both the possible presence of viral particles in tears and conjunctiva, and the potential for conjunctival transmission remain controversial. Ocular manifestations are not frequent and could resemble viral infection of the ocular surface. Most recommendations are based on the strategies implemented by Asian countries during previous coronavirus outbreaks. There is a need for substantive studies evaluating these strategies in the setting of SARS-CoV-2. In the meantime, plans for applying these measures must be implemented with caution, taking into account the context of each individual country, and undergo regular evaluation. |COVID-19[MESH] |Conjunctiva/virology[MESH] |Coronavirus Infections/*complications/prevention & control/transmission[MESH] |Evidence-Based Medicine[MESH] |Eye Diseases/*complications[MESH] |Humans[MESH] |Ophthalmology[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/*complications/prevention & control/transmission[MESH] |Review Literature as Topic[MESH]COVID-19 and the eye: how much do we really know? A best evidence revi(epmc).pdf DeepDyve Pubget Overpricing